Hamilton Thomas Edward bought Larimar Therapeutics ($LRMR) shares once on the open market in the last year, investing $500,000 total. His most recent purchase occurred on February 27, 2026. Among nearly 5,000 insiders tracking open market buys, his purchase amount ranks 847th, below the average of about $1.5 million across roughly 3.3 transactions per insider. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2026 | Larimar Therapeutics, Inc. | $LRMR | Hamilton Thomas Edward | Not found | P | Common Stock | 100000 | $5.00 | 824,231.0000 | 85,590,392 | 13.81% | 0.12% |
| May 14, 2025 | ANNALY CAPITAL MANAGEMENT INC | $NLY | Hamilton Thomas Edward | Director | A | Deferred Stock Units | 8961 | $0.00 | 45,243.0000 | 578,357,904 | 24.70% | 0.00% |
| May 13, 2025 | Larimar Therapeutics, Inc. | $LRMR | Hamilton Thomas Edward | Director | A | Stock Option (Right to Buy) | 19000 | $0.00 | 19,000.0000 | 63,815,065 | 9999.99% | 0.03% |
| May 29, 2024 | Larimar Therapeutics, Inc. | $LRMR | Hamilton Thomas Edward | Director | A | Stock Option (Right to Buy) | 19000 | $0.00 | 19,000.0000 | 43,909,069 | 9999.99% | 0.04% |
| Feb. 16, 2024 | Larimar Therapeutics, Inc. | $LRMR | Hamilton Thomas Edward | Director | P | Common Stock | 57208 | $8.74 | 724,231.0000 | 43,909,069 | 8.58% | 0.13% |
| May 15, 2024 | ANNALY CAPITAL MANAGEMENT INC | $NLY | Hamilton Thomas Edward | Director | A | Deferred Stock Units | 8583 | $0.00 | 36,282.0000 | 0 | 30.99% | 0.00% |
| May 17, 2023 | ANNALY CAPITAL MANAGEMENT INC | $NLY | Hamilton Thomas Edward | Director | A | Deferred Stock Units | 8167 | $0.00 | 27,698.0000 | 0 | 41.82% | 0.00% |